Kansas City, KS. Pat Butler, a long-time athletic director, shares his journey with metastatic prostate cancer, highlighting his students' support through "Butler's Brigade," which raised $10,000 for the University of Kansas Cancer Center. Dr. Blaine Knox and Dr. William Parker discuss treatment options, emphasizing the importance of early detection and personalized medicine. They also address the role of PSA testing and the potential for targeted therapies like pluvicto.
Pat Butler, patient
• Pat Butler describes his initial symptoms, including feeling run down and back pain, which he initially attributed to aging.
• He discusses his treatment plan, which included six rounds of chemotherapy and hormone blockers.
Dr. Blaine Knox- Medical Oncologist, The University of Kansas Cancer Center
• Dr. Blaine Knox explains the concept of metastatic prostate cancer and the importance of systemic therapies
• He highlights the ongoing research and clinical trials at the University of Kansas Cancer Center to advance prostate cancer treatments.
Dr. William Parker, Urological Oncologist, The University of Kansas Cancer Center
• Dr. Parker emphasizes the importance of understanding the patient's goals and quality of life when deciding on treatment options.
• He encourages men to be proactive about their health and follow screening guidelines.
Morning Rounds: Stroke Awareness
Dr. Joe Wend, Vascular Neurologist, The University of Kansas Health System
• Dr. Wend explains that stroke risk factors include high blood pressure, high cholesterol, tobacco use, diabetes, heavy drinking, and obesity.
• He introduces the "BE FAST" mnemonic for stroke symptoms: Balance, Eyes, Face, Arm, Speech, and Time.
• He explains the free quiz people can take through the health system Stroke Risk Assessment
